Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

14.57
BATS BZX Real-Time Price
As of 2:51pm ET
 +2.22 / +17.93%
Today’s Change
11.57
Today|||52-Week Range
116.75
-58.37%
Year-to-Date
What's Causing Clovis Oncology Shares to Skyrocket Today?
2:26pm / MotleyFool.com - Paid Partner Content
5 Reasons to Hate Biotech Stocks
Jun 23 / MotleyFool.com - Paid Partner Content
16 Biopharma Companies Besides Medivation That Are Attractive Targets
1:31pm / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close12.36
Today’s open13.93
Day’s range13.89 - 15.31
Volume298,833
Average volume (3 months)1,287,353
Market cap$474.3M
Dividend yield--
Data as of 2:51pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-107.42%
Earnings growth (this year)+17.63%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
OTICOtonomy Inc+0.15+0.96%
VNDAVanda Pharmaceutical...-0.03-0.27%
SGNTSagent Pharmaceutica...+0.15+1.01%
LOXOLoxo Oncology Inc+0.76+3.32%
Data as of 2:52pm ET, 06/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$2.12
Annual revenue (last year)$0.00
Annual profit (last year)-$352.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
VP, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers

Search for Jobs